Evaluating subcutaneous implantable cardioverter defibrillators in hypertrophic cardiomyopathy: fewer complications without increased therapies

1 April 2025 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Implantable cardioverter-defibrillator therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

ESC 365 is supported by

ESC 365 is supported by